Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT. “A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.” BJU International 2014, June epub. PMID: 24952954. Link: http://www.ncbi.nlm.nih.gov/pubmed/24952954
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT. “Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.” BJU International 2014 Jan epub. PMID: 24712975. Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
Prabhu V, Lee T, Loeb S, Holmes JH, Gold HT, Lepor H, Penson DF, and Makarov DV. “Twitter Response to the United States Preventive Services Task Force Recommendations Against Screening with Prostate Specific Antigen.” BJU International 2014 epub. PMID: 24661474 Link: http://www.ncbi.nlm.nih.gov/pubmed/24661474
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT. “Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.” BJU International 2014 Jan epub. PMID: 24712975. Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
McGuire BB, Helfand BT, Loeb S, Hu Q, O’Brien D, Cooper P, Yang X, and Catalona WJ. “Outcomes in Patients with Gleason Score 8-10 Prostate Cancer: Relation to Preoperative PSA Level.” BJU International June 2012; 109: 1764-9. PMID: 22017732. Link: http://www.ncbi.nlm.nih.gov/pubmed/22017732
Loeb S and Carter HB. “Should prostate-specific antigen velocity be abandoned?” Asian Journal of Andrology 2011; 12: 359. PMID: 21499277. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739355/
Loeb S and Catalona WJ. “What is the Role of Digital Rectal Examination in Men Undergoing Serial Screening of Serum PSA?” Nature Clinical Practice Urology, February 2009; 6: 68. Link: http://www.ncbi.nlm.nih.gov/pubmed/19139742
Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ. “Personalized PSA Testing Using Genetic Variants May Reduce Unnecessary Biopsies.” Journal of Urology 2012; epub December. PMID: 23246478. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631301/
Carvalhal GF, Daudi SN, Kan D, Mondo D, Roehl KA, Loeb S, and Catalona WJ. “Correlation Between Serum Prostate-Specific Antigen and Cancer Volume in Prostate Glands of Different Sizes.” Urology, September 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20846711
Loeb S, Carvalhal GF, Kan D, Desai A, and Catalona WJ. “External Validation of the Cancer of the Prostate Risk Assessment (CAPRA) Score in a Single-Surgeon Radical Prostatectomy Series.” Urologic Oncology: Seminars and Original Investigations, September 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20822930
Loeb S. “Editorial Comment Re: Evaluation of Prostate Specific Antigen Acceleration for Prostate Cancer Diagnosis.” Journal of Urology March 2011; 185: 826. PMID: 21239022. Link: http://www.ncbi.nlm.nih.gov/pubmed/21239022
Loeb S, Kettermann A, Carter HB, Ferrucci L, Metter EJ, and Walsh PC. “Does Prostate Growth Confound PSA Velocity: Data from the Baltimore Longitudinal Study of Aging.” Journal of Urology, 2008; 180: 1314 Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575041/
Loeb S, Gashti SN, and Catalona WJ. “Exclusion of Inflammation in the Differential Diagnosis of an Elevated Prostate-Specific Antigen (PSA).” Urologic Oncology: Seminars and Original Investigations, Jan-Feb 2009; 27: 64. Link: http://www.ncbi.nlm.nih.gov/pubmed/19111800
Reinhardt D, Helfand BT, Cooper PR, Roehl KA, Catalona WJ, and Loeb S. “Prostate Cancer Risk Alleles are Associated with Prostate Cancer Tumor Volume and Prostate Size.” Journal of Urology 2013; epub Dec 14. PMID: 24345439 Link: http://www.ncbi.nlm.nih.gov/pubmed/24345439
Loeb S, Schaeffer EM, Trock BJ, Humphreys EB, Epstein JI, and Walsh PC. “What are the Outcomes of Radical Prostatectomy for High-Risk Prostate Cancer?” Urology 2009, Nov 19 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19931898
Loeb S and Partin AW. “PCA3 Urinary Biomarker for Prostate Cancer.” Reviews in Urology Fall 2010; 12: e205. PMID: 21234266. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020285/
Meeks JJ, Thaxton CS, Loeb S, Roehl KA, Helfand BT, and Catalona WJ. “Comparison of PSA Velocity of Screened Versus Referred Patients with Prostate Cancer.” Journal of Urology 2008; 179: 1340. Link: http://www.ncbi.nlm.nih.gov/pubmed/18289590
Loeb S, Yu X, Roehl KA, Nadler RB and Catalona WJ. “PSA Velocity Thresholds in Men with Total PSA <4 ng/ml.” Journal of Urology, December 2007; 178; 2348. Link: http://www.ncbi.nlm.nih.gov/pubmed/17936844
Yu X, Loeb S, Han M, Suarez BK, Roehl KA, and Catalona WJ. “The Association Between Total PSA and PSA Velocity.” Journal of Urology, April 2007; 177: 1298. Link: http://www.ncbi.nlm.nih.gov/pubmed/17382716
Loeb S, Roehl KA, Catalona WJ, and Nadler RB. “PSA Velocity Threshold for Predicting Prostate Cancer in Young Men.” Journal of Urology, March 2007; 177: 899. Link: http://www.ncbi.nlm.nih.gov/pubmed/17296371
Loeb S, Roehl KA, Yu X, Han M, and Catalona WJ. “Use of PSAV to Follow Patients with Isolated High-Grade Prostatic Intraepithelial Neoplasia (HG-PIN) on Prostate Biopsy.” Urology, January 2007; 69: 108. Link: http://www.ncbi.nlm.nih.gov/pubmed/17270629
Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, and Catalona WJ. “Comparison of Different Methods for Calculating PSA Velocity: Importance of Time Interval Prior to Diagnosis of Prostate Cancer.” Journal of Urology, December 2006; 176: 2427. Link: http://www.ncbi.nlm.nih.gov/pubmed/17085120
Loeb S, Han M, Roehl KA, Antenor JV, and Catalona WJ. “Accuracy of Prostate Weight Estimation by Digital Rectal Exam (DRE) Versus Transrectal Ultrasonography (TRUS).” Journal of Urology, January 2005; 173: 63-5. Link: http://www.ncbi.nlm.nih.gov/pubmed/15592029
Loeb S and Catalona WJ. “Diagnosis and Treatment of Prostate Cancer. Beyond the controversy over whether and whom to screen, the appropriate method of screening is also subject to debate.” Medical Economics, December 2008; 85: 36. Link: http://www.ncbi.nlm.nih.gov/pubmed/19209648
Loeb S, Carter HB, Schaeffer EM, Ferrucci L, Kettermann A, and Metter EM. “Should Prostate-specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging.” Journal of Urology, December 2009; 182: 2646. Link: http://www.ncbi.nlm.nih.gov/pubmed/19836806
Loeb S, Carter HB, Walsh PC, Isaacs WB, Kettermann A, Tanaka T, Ferrucci L, and Metter EJ. “Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate-Specific Antigen Level.” Journal of Urology, July 2009; 182: 101. Link: http://www.ncbi.nlm.nih.gov/pubmed/19450841
Loeb S. “Editorial Comment on: Serial Prostate Biopsy and Risk of Lower Urinary Tract Symptoms: Results From a Large, Single-Institution Active Surveillance Cohort.” Urology 2014; 83 (1): 38-19. PMID: 24246328 Link: http://www.ncbi.nlm.nih.gov/pubmed/24246328
Vellekoop A and Loeb S. “Editorial Comment on A Single Dose of 240 mg Gentamicin During Transrectal Prostate Biopsy Significantly Reduces Septic Complications.” Urology 2013 epub August. Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=23992969
Loeb S. “Editorial Comment on ‘Screening Rectal Culture to Identify Fluoroquinolone-Resistant Organisms Before Transrectal Prostate Biopsy: Do the Culture Results Between Office Visit and Biopsy Correlate?” Urology 2013; 82: 71. Link: http://www.ncbi.nlm.nih.gov/pubmed/23806392
Helfand BT, Mongiu AK, Kan D, Kim DY, Loeb S, Roehl KA, Meeks JJ, Smith ND, and Catalona WJ. “Outcomes of Radical Prostatectomy for Patients with Clinical Stage T1a and T1b Disease.” BJU International, February 2009 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/19239451
Loeb S, Roehl KA, Thaxton CS, and Catalona WJ. “Combined Prostate-Specific Antigen Density and Biopsy Features to Predict ‘Clinically Insignificant’ Prostate Cancer.” Urology, July 2008; 72: 143. Link: http://www.ncbi.nlm.nih.gov/pubmed/18436287
Tosoian J and Loeb S. “PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.” TheScientificWorldJOURNAL: TSW Urology October 2010; 10: 1919–1931. Link: http://www.ncbi.nlm.nih.gov/pubmed/20890581
Catalona WJ and Loeb S. “Commentary on the Recommendations of The American College of Preventive Medicine on Prostate Cancer Screening.” Medscape Urology (online)
Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ. “Genetic Sequence Variants are Associated with Severity of Lower Urinary Tract Symptoms and Prostate Cancer Susceptibility.” Journal of Uroloy 2012 epub November. PMID: 23159463. Link: http://www.ncbi.nlm.nih.gov/pubmed/23159463
Loeb S, Hernandez DH, Mangold LA, Humphreys EB, Agro M, Walsh PC, Partin AW, and Han M. “Progression after Radical Prostatectomy for Men in their Thirties Compared to Older Men.” BJU International, June 2008; 101: 1503. Link: http://www.ncbi.nlm.nih.gov/pubmed/18341626
Okotie O, Roehl KA, Han M, Loeb S, Gashti SN, and Catalona WJ. “Characteristics of Prostate Cancer Detected by Digital Rectal Examination Only.” Urology 2007; 70: 1117. Link: http://www.ncbi.nlm.nih.gov/pubmed/18158030
Loeb S and Carter HB. “Limitations and Use of PSA Derivatives in the Screening and Risk Stratification of Prostate Cancer.” Urologic Oncology: Seminars and Original Investigations, Nov-Dec 2009; 27: 583. Link: http://www.ncbi.nlm.nih.gov/pubmed/19879470
Graif T, Yu Y, Loeb S, Gashti SN, Griffin S, Han M, Roehl KA, Suarez BK, and Catalona WJ. “Underdiagnosis and Overdiagnosis of Prostate Cancer.” Journal of Urology 2007; 178: 88. Link: http://www.ncbi.nlm.nih.gov/pubmed/17499308
Loeb S and Catalona WJ. “What to do with an abnormal PSA test.” The Oncologist, March 2008; 13: 299. Link: http://www.ncbi.nlm.nih.gov/pubmed/18378540
Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, and Catalona WJ. “Characteristics of Prostate Cancers Detected at Prostate-Specific Antigen Levels Less than 2.5 ng/ml.” Journal of Urology, June 2009; 181: 2515. Link: http://www.ncbi.nlm.nih.gov/pubmed/19371879